Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy

A Systematic Review and Meta-analysis

Sankar D. Navaneethan, Sonal Singh, Suresh Appasamy, Richard E. Wing, Ashwini R. Sehgal

Research output: Contribution to journalArticle

150 Citations (Scopus)

Abstract

Background: Optimal hydration measures to prevent contrast-induced nephropathy are controversial. Study Design: We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings. Setting & Population: Adult patients undergoing contrast procedures. Selection Criteria for Studies: Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy. Intervention: Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine. Outcomes: Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure. Results: Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy. Limitation: Publication bias and heterogeneity. Conclusion: Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

Original languageEnglish (US)
Pages (from-to)617-627
Number of pages11
JournalAmerican Journal of Kidney Diseases
Volume53
Issue number4
DOIs
StatePublished - Apr 1 2009
Externally publishedYes

Fingerprint

Sodium Bicarbonate
Meta-Analysis
Odds Ratio
Confidence Intervals
Acetylcysteine
Renal Replacement Therapy
Hospital Mortality
Therapeutics
Heart Failure
Publication Bias
MEDLINE
Patient Selection
Randomized Controlled Trials
Databases
Incidence
Population

Keywords

  • acute renal failure
  • contrast-induced nephropathy
  • Hydration
  • sodium bicarbonate

ASJC Scopus subject areas

  • Nephrology

Cite this

Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy : A Systematic Review and Meta-analysis. / Navaneethan, Sankar D.; Singh, Sonal; Appasamy, Suresh; Wing, Richard E.; Sehgal, Ashwini R.

In: American Journal of Kidney Diseases, Vol. 53, No. 4, 01.04.2009, p. 617-627.

Research output: Contribution to journalArticle

Navaneethan, Sankar D. ; Singh, Sonal ; Appasamy, Suresh ; Wing, Richard E. ; Sehgal, Ashwini R. / Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy : A Systematic Review and Meta-analysis. In: American Journal of Kidney Diseases. 2009 ; Vol. 53, No. 4. pp. 617-627.
@article{eb1c5ca4f83c40d4a013ec5a4d188f37,
title = "Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis",
abstract = "Background: Optimal hydration measures to prevent contrast-induced nephropathy are controversial. Study Design: We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings. Setting & Population: Adult patients undergoing contrast procedures. Selection Criteria for Studies: Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy. Intervention: Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine. Outcomes: Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure. Results: Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95{\%} confidence interval [CI], 0.26 to 0.82; I2 = 55.9{\%}) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95{\%} CI, 0.16 to 1.53; I2 = 0{\%}), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95{\%} CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95{\%} CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95{\%} CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95{\%} CI, 0.10 to 0.64; I2 = 63.3{\%}), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95{\%} CI, 0.46 to 1.57; I2 = 25.9{\%}) in risk of contrast-induced nephropathy. Limitation: Publication bias and heterogeneity. Conclusion: Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.",
keywords = "acute renal failure, contrast-induced nephropathy, Hydration, sodium bicarbonate",
author = "Navaneethan, {Sankar D.} and Sonal Singh and Suresh Appasamy and Wing, {Richard E.} and Sehgal, {Ashwini R.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1053/j.ajkd.2008.08.033",
language = "English (US)",
volume = "53",
pages = "617--627",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy

T2 - A Systematic Review and Meta-analysis

AU - Navaneethan, Sankar D.

AU - Singh, Sonal

AU - Appasamy, Suresh

AU - Wing, Richard E.

AU - Sehgal, Ashwini R.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Background: Optimal hydration measures to prevent contrast-induced nephropathy are controversial. Study Design: We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings. Setting & Population: Adult patients undergoing contrast procedures. Selection Criteria for Studies: Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy. Intervention: Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine. Outcomes: Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure. Results: Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy. Limitation: Publication bias and heterogeneity. Conclusion: Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

AB - Background: Optimal hydration measures to prevent contrast-induced nephropathy are controversial. Study Design: We conducted a systematic review and meta-analysis using the MEDLINE database (1966 to January 2008), EMBASE (January 2008), and abstracts from conference proceedings. Setting & Population: Adult patients undergoing contrast procedures. Selection Criteria for Studies: Randomized controlled trials comparing intravenous hydration with sodium bicarbonate with hydration with intravenous normal saline for prevention of contrast-induced nephropathy. Intervention: Hydration with intravenous sodium bicarbonate with or without N-acetylcysteine versus hydration with normal saline with or without N-acetylcysteine. Outcomes: Contrast-induced nephropathy, need for renal replacement therapy, and worsening of heart failure. Results: Twelve trials (1,854 participants) were included. Sodium bicarbonate significantly decreased the risk of contrast-induced nephropathy (12 trials, 1,652 patients; odds ratio [OR], 0.46; 95% confidence interval [CI], 0.26 to 0.82; I2 = 55.9%) without a significant difference in need for renal replacement therapy (9 trials, 1,215 patients; OR, 0.50; 95% CI, 0.16 to 1.53; I2 = 0%), in-hospital mortality (11 trials, 1,640 patients; OR, 0.51; 95% CI, 0.15 to 1.69), or congestive heart failure compared with controls. Similar results were seen for the risk of contrast-induced nephropathy when sodium bicarbonate was compared with normal saline alone (OR, 0.39; 95% CI, 0.20 to 0.77), but not when sodium bicarbonate/N-acetylcysteine combination was compared with N-acetylcysteine/normal saline combination (OR, 0.68; 95% CI, 0.34 to 1.37). A subgroup analysis limited to published trials showed similar results (OR, 0.26; 95% CI, 0.10 to 0.64; I2 = 63.3%), whereas unpublished studies showed a nonsignificant decrease (OR, 0.85; 95% CI, 0.46 to 1.57; I2 = 25.9%) in risk of contrast-induced nephropathy. Limitation: Publication bias and heterogeneity. Conclusion: Hydration with sodium bicarbonate decreases the incidence of contrast-induced nephropathy in comparison to hydration with normal saline without a significant difference in need for renal replacement therapy and in-hospital mortality. Larger studies analyzing patient-centered outcomes are needed.

KW - acute renal failure

KW - contrast-induced nephropathy

KW - Hydration

KW - sodium bicarbonate

UR - http://www.scopus.com/inward/record.url?scp=62749137422&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62749137422&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2008.08.033

DO - 10.1053/j.ajkd.2008.08.033

M3 - Article

VL - 53

SP - 617

EP - 627

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -